Skip to Main Content

Author Details

David Veesler
2008
161
61
PMIDPaper TitleJournal TitlePublished Year
37503272Hierarchical design of pseudosymmetric protein nanoparticles.Res Sq2023
37856551Regulatory T cell-like response to SARS-CoV-2 in Jamaican fruit bats (Artibeus jamaicensis) transduced with human ACE2.PLoS Pathog2023
38014024Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades.2023
37905007Local structural flexibility drives oligomorphism in computationally designed protein assemblies.bioRxiv2023
37645760Structure and design of Langya virus glycoprotein antigens.2023
38096058Antigen spacing on protein nanoparticles influences antibody responses to vaccination.2023
37989312Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus.2023
38076876Persistent immune imprinting after XBB.1.5 COVID vaccination in humans.2023
36841235Virus structures and molecular biology exchange glances.2023
36711984Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.bioRxiv2023
36824814Regulatory T Cell-like Response to SARS-CoV-2 in Jamaican Fruit Bats ( <i>Artibeus jamaicensis</i> ) Transduced with Human ACE2.bioRxiv2023
36711543Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.bioRxiv2023
37398374Hierarchical design of pseudosymmetric protein nanoparticles.bioRxiv2023
37075079A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.PLoS Pathog2023
37300832Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.Cell Rep2023
36859493Automatic and accurate ligand structure determination guided by cryo-electron microscopy maps.Nat Commun2023
37292995Antigen spacing on protein nanoparticles influences antibody responses to vaccination.2023
37163615Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.Sci Transl Med2023
35076256Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.Science2022
35705092Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.Cell Reports Medicine2022
35762884Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.Science2022
35700730Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein.Cell2022
35446645Computational design of mechanically coupled axle-rotor protein assemblies.Science2022
36356052SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.Sci Immunol2022
35383176Structure-based design of stabilized recombinant influenza neuraminidase tetramers.Nat Commun2022
35879941Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.eClinicalMedicine2022
36206752Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens.Cell Reports Medicine2022
35617431Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant.Proceedings of the National Academy of Sciences of the United States of America2022
35484405Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants.Nat Biotechnol2022
36203553Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.bioRxiv2022
35864232Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.Nature2022
35677069Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.bioRxiv2022
35988541Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.Cell Rep2022
35412328Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.Sci Transl Med2022
36264829Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.Science2022
35857703ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.Science2022
35857529Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.Science2022
35606518Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.NPJ Vaccines2022
36399443Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.PLoS Pathogens2022
35976993Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.Sci Transl Med2022
34990214Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.Science2022
35313570Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines.bioRxiv2022
35239409Architecture and antigenicity of the Nipah virus attachment glycoprotein.Science2022
35134084A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy.PLoS Pathogens2022
35016195Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.Nature2022
35118471Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.bioRxiv2022
35114688ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.Nature2022
35123650SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.Cell2022
34931194Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.bioRxiv2021
33809833Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus.Viruses2021
  • 1 - 50 of 161

Recommended Authors

Collaborators

Co-authored papers 78
Co-authored papers 26
Co-authored papers 22
Aix Marseille University and CNRS
Co-authored papers 18
Vir Biotechnology Inc.
Co-authored papers 16
University of Washington
Co-authored papers 16
Washington University School of Medicine
Co-authored papers 13
University of Washington
Co-authored papers 13
University of California san francisco
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 9
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8
University of California san francisco
Co-authored papers 7
Co-authored papers 7
Washington University School of Medicine
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Columbia University
Co-authored papers 5
Co-authored papers 5
University of North Carolina
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of Washington
Co-authored papers 5
Fred Hutchinson Cancer Center
Co-authored papers 5